RET and multiple endocrine neoplasia type 2A: Nevertheless, in a recent study by Robledo et al [19], it has been clearly suggested that the presence of G91S/S904S polymorphisms of the RET is related to the early appearance of symptoms in MEN 2A patients, and therefore, these polymorphisms could be considered as genetic modifiers.